Pilot clinical trial of an anti-TNF monoclonal antibody for the treatment of septic shock

By BOILLOT A   CAPELLIER G   RACADOT E   WIJDENES J   HERVE P   BARALE F  

Clinical Intensive Care, Vol. 6, Iss. 2, 1995-04 ,pp. : 52-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies

By  

Current Drug Therapy, Vol. 11, Iss. 1, 2016-04 ,pp. : 21-40

Bentham Science Publishers

Access to resources Recommend Favorite

Blood nitrate levels in septic and cardiogenic shock

By TAGAN D   ECKERT P   MARKERT M   FEIHL F   SCHALLER M-D  

Clinical Intensive Care, Vol. 9, Iss. 2, 1998-04 ,pp. : 71-76

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Dobutamine and dopexamine and the splanchnic metabolic response in septic shock

By REINELT H   RADERMACHER R   FISCHER G   GEISSER W   TRUNK E   WIEDECK H   MEZODY M   GEORGIEFF M   VOGT J  

Clinical Intensive Care, Vol. 8, Iss. 1, 1997-02 ,pp. : 38-41

Ashgate Publishing Ltd

Access to resources Recommend Favorite

N-acetylcysteine and cardiac dysfunction in human septic shock

By Spapen H D   Nguyen D N   Elst K ver   Heyden Y vander   Huyghens L P  

Clinical Intensive Care, Vol. 13, Iss. 1, 2002-03 ,pp. : 27-32

Ashgate Publishing Ltd

Access to resources Recommend Favorite